Agilent Technologies Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 8/26/2026)
| Balance Sheet | Total Assets | 12,727,000,000.00 | ROE | 52.97 % |
| Balance Sheet | Total Equity | 6,741,000,000.00 | ROA | 10.24 % |
| Cashflow | Capital Expenditures | -407,000,000.00 | P/FCF | 42.90 |
| Cashflow | Free Cash Flow | 1,152,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 1,559,000,000.00 | P/CF | 31.70 |
| Income | Earnings per Share (diluted) | 4.59 | Div. Yield | 0.57 % |
| Income | Net Income | 400,672,440.90 | P/E | 37.91 |
| Income | Shares Outstanding | 284,000,000.00 | P/B | 7.33 |
| Income | Total Revenue | 1,861,000,000.00 | P/S | 23.13 |
Ratios calculated on: 10/14/2026
Company Description
Agilent Technologies, Inc. (Agilent) is a measurement company providing bio-analytical and electronic measurement solutions to the communications, electronics, life sciences and chemical analysis industries. During the fiscal year ended October 31, 2011 (fiscal 2011), it had three business segments: electronic measurement business, chemical analysis business and life sciences business. Its electronic measurement business addresses the communications, electronics and other industries. Agilent's chemical analysis business focuses on the petrochemical, environmental, forensics and food safety industries. Its life sciences business focuses on the pharmaceutical, biotechnology, academic and Government, bio-agriculture and food safety industries. In addition to its three businesses, it conducts research through Agilent Technologies Laboratories (Agilent Labs). In June 2012, the Company acquired cancer diagnostics company, Dako. In August 2012, the Company acquired Aurora SFC Systems, Inc.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.agilent.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more